Page 472 - Read Online
P. 472

Page 24 of 40                         Maner et al. J Cancer Metastasis Treat 2020;6:37  I  http://dx.doi.org/10.20517/2394-4722.2020.60
































               Figure 10. Significant signaling pathways in melanoma. Schematic of major pathways associated with cell survival, differentiation, and
               proliferation. Arrows represent active signals and red lines represent inhibitory signals. mTOR: mammalian target of rapamycin; MITF:
               microphthalmia-associated transcription factor


               of NRAS, BRAF, and c-kit pathways, proteins expressed in the MAPK signaling pathway has been found
               suggesting crosstalk between pathways [167] . In addition, several mutations of key upstream proteins of
               the aforementioned MAPK cascade includes NRAS, KIT, GNAQ, and GNA11  [168] . In over 80% of uveal
               melanomas, GNAQ or GNA11 is activated using the MAPK pathway [169] .

               PI3K-AKT pathway
               The neuroblastoma RAS viral oncogene (NRAS) is mutated in approximately 30% of melanomas [168] . Ras
               binds to PI3K activating secondary messenger PIP3 and binds to serine threonine kinase AKT [170] . An
               important downstream effector of PI3K-AKT is mTOR [Figure 10], which functions to initiate a cascade
               that inhibits autophagy [160,171] . PTEN is an antagonist of PI3K-mediated signaling. Loss of functional tumor
               suppressor gene PTEN increases AKT phosphorylation leading to decreased apoptosis and increased
               melanoma survivability [165] . PTEN mutation was also found in nearly 44% of BRAF mutated melanomas in
               contrast to 4% of NRAS mutated melanomas [168] . These mutational patterns suggest that BRAF and NRAS
               mutations appear to be mutually exclusive and distinct oncogenic drivers [170] .

               c-KIT inhibition
               c-KIT encodes for transmembrane tyrosine kinase KIT which binds to stem cell factor and activates
               cellular proliferation pathways including RAS-ERK and PI3K/AKT [Figure 10] [162,172] . KIT mutations were
               more frequently in mucosal, acral, and chronically sun-damaged skin melanoma than in non-chronic sun-
               damaged skin melanoma in the United States [173] . Of note, KIT mutations are believed to be more frequent
               in non-white populations and reported in higher mutation rates in East Asian patients [174,175] .

               Supporting stroma and vascularization
               HIF-1α/VEGF
               Tumors require vascularization to grow, metastasize, and invade. Angiogenesis correlates with the
               progression of melanoma tumor growth by supplying oxygen and nutrients and providing an opportunistic
               route to spread into blood circulation. VEGF is an important angiogenic factor and leads to secretion of
   467   468   469   470   471   472   473   474   475   476   477